209 related articles for article (PubMed ID: 20434776)
1. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
[TBL] [Abstract][Full Text] [Related]
2. Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity.
Xie MJ; Niu YF; Yang XD; Liu WP; Li L; Gao LH; Yan SP; Meng ZH
Eur J Med Chem; 2010 Dec; 45(12):6077-84. PubMed ID: 21036421
[TBL] [Abstract][Full Text] [Related]
3. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
4. A new insulin-enhancing agent: [N,N'-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity.
Xie MJ; Li L; Yang XD; Liu WP; Yan SP; Niu YF; Meng ZH
Eur J Med Chem; 2010 Jun; 45(6):2327-35. PubMed ID: 20207051
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
6. In vivo insulin-mimetic activity of [N,N'-1,3-propyl-bis(salicyladimine)]oxovanadium(IV).
Xie M; Xu G; Li L; Liu W; Niu Y; Yan S
Eur J Med Chem; 2007 Jun; 42(6):817-22. PubMed ID: 17343957
[TBL] [Abstract][Full Text] [Related]
7. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
8. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
9. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
10. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
11. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
12. A new candidate for insulinomimetic vanadium complex: synergism of oxovanadium(IV)porphyrin and sodium ascorbate.
Sakurai H; Inohara T; Adachi Y; Kawabe K; Yasui H; Takada J
Bioorg Med Chem Lett; 2004 Mar; 14(5):1093-6. PubMed ID: 14980642
[TBL] [Abstract][Full Text] [Related]
13. Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.
Monga V; Thompson KH; Yuen VG; Sharma V; Patrick BO; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2678-88. PubMed ID: 15819553
[TBL] [Abstract][Full Text] [Related]
14. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
15. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
16. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats.
Ramachandran B; Sekar DS; Kandaswamy M; Narayanan V; Subramanian S
Exp Diabesity Res; 2004; 5(2):137-42. PubMed ID: 15203884
[TBL] [Abstract][Full Text] [Related]
18. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and antidiabetic properties of N(1)-2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV).
Yanardag R; Demirci TB; Ulküseven B; Bolkent S; Tunali S; Bolkent S
Eur J Med Chem; 2009 Feb; 44(2):818-26. PubMed ID: 18621448
[TBL] [Abstract][Full Text] [Related]
20. Vanadium-induced formation of thiadiazole and thiazoline compounds. Mononuclear and dinuclear oxovanadium(v) complexes with open-chain and cyclized thiosemicarbazone ligands.
Rubcić M; Milić D; Horvat G; Dilović I; Galić N; Tomisić V; Cindrić M
Dalton Trans; 2009 Nov; (44):9914-23. PubMed ID: 19885541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
